Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and Hyperinsulinism

cetylpyridinium chloride anhydrous has been researched along with Hyperinsulinism in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akrouh, A; Halcomb, SE; Nichols, CG; Sala-Rabanal, M1
Asplin, KE; McGowan, CM; Pollitt, CC; Sillence, MN1
Hill, M; Kazdová, L; Klementová, M; Kopecký, J; Krusinová, E; Mlejnek, P; Pelikánová, T; Pravenec, M; Wohl, P1

Reviews

1 review(s) available for cetylpyridinium chloride anhydrous and Hyperinsulinism

ArticleYear
Molecular biology of K(ATP) channels and implications for health and disease.
    IUBMB life, 2009, Volume: 61, Issue:10

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; ATP-Binding Cassette Transporters; Diabetes Mellitus; Disease; Health; Humans; Hyperinsulinism; KATP Channels; Molecular Biology; Mutation; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Sulfonylurea Receptors

2009

Trials

2 trial(s) available for cetylpyridinium chloride anhydrous and Hyperinsulinism

ArticleYear
Induction of laminitis by prolonged hyperinsulinaemia in clinically normal ponies.
    Veterinary journal (London, England : 1997), 2007, Volume: 174, Issue:3

    Topics: Animals; Blood Glucose; Drug Administration Schedule; Female; Glucose Clamp Technique; Health; Hoof and Claw; Horse Diseases; Horses; Hyperinsulinism; Inflammation; Insulin; Male

2007
Effect of acute hyperinsulinaemia with and without angiotensin II type 1 receptor blockade on resistin and adiponectin concentrations and expressions in healthy subjects.
    European journal of endocrinology, 2007, Volume: 157, Issue:4

    Topics: Adiponectin; Adult; Angiotensin II Type 1 Receptor Blockers; Drug Combinations; Gene Expression; Glucose Clamp Technique; Health; Humans; Hyperinsulinism; Insulin; Intra-Abdominal Fat; Losartan; Male; Receptor, Angiotensin, Type 1; Resistin

2007